Daiwa Securities Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-160
| Closed | -$4K | – | 1439 |
|
|
2025
Q4 | $4K | Hold |
160
| – | – | ﹤0.01% | 1260 |
|
|
2025
Q3 | $3K | Hold |
160
| – | – | ﹤0.01% | 1254 |
|
|
2025
Q2 | $2K | Hold |
160
| – | – | ﹤0.01% | 1234 |
|
|
2025
Q1 | $2K | Hold |
160
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q4 | $2K | Hold |
160
| – | – | ﹤0.01% | 1236 |
|
|
2024
Q3 | $2K | Buy |
160
+112
| +233% | +$1.66K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $1K | Hold |
48
| – | – | ﹤0.01% | 1302 |
|
|
2024
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 1310 |
|
|
2023
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 1350 |
|
|
2023
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 1323 |
|
|
2022
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 1394 |
|
|
2022
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 1405 |
|
|
2022
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 1434 |
|
|
2022
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 1424 |
|
|
2021
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 1450 |
|
|
2021
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 1287 |
|
|
2021
Q2 | $1K | Hold |
48
| – | – | ﹤0.01% | 1218 |
|
|
2021
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 1229 |
|
|
2020
Q4 | $1K | Sell |
48
-70
| -59% | -$1.47K | ﹤0.01% | 1208 |
|
|
2020
Q3 | $2K | Hold |
118
| – | – | ﹤0.01% | 1146 |
|
|
2020
Q2 | $32K | Hold |
118
| – | – | ﹤0.01% | 981 |
|
|
2020
Q1 | $2K | Hold |
118
| – | – | ﹤0.01% | 1167 |
|
|
2019
Q4 | $3K | Sell |
118
-15
| -11% | -$409 | ﹤0.01% | 1149 |
|
|
2019
Q3 | $3K | Sell |
133
-17
| -11% | -$556 | ﹤0.01% | 1109 |
|
|
2019
Q2 | $5K | Hold |
150
| – | – | ﹤0.01% | 1105 |
|
|
2019
Q1 | $6K | Buy |
+150
| New | +$6.29K | ﹤0.01% | 1071 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
